Literature DB >> 29091005

Thyroid Nodules With Nondiagnostic Cytologic Results: Follow-Up Management Using Ultrasound Patterns Based on the 2015 American Thyroid Association Guidelines.

Chae Jung Park1, Eun-Kyung Kim1, Hee Jung Moon1, Jung Hyun Yoon1, Vivian Youngjean Park1, Jin Young Kwak1.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the malignancy rate of nodules with nondiagnostic cytologic results based on the American Thyroid Association (ATA) ultrasound (US) patterns and to suggest management guidelines for these nodules.
MATERIALS AND METHODS: From January 2013 to December 2014, 441 nodules (≥ 1 cm) were found in 437 patients with nondiagnostic results of ultrasound (US)-guided fine-needle aspiration biopsy (nondiagnostic nodules). A total of 191 nodules that were cytopathologically confirmed or were smaller (> 3 mm) at follow-up US were enrolled. The US findings of each nodule were reviewed. One radiologist classified the nodules into the following five categories according to the 2015 ATA guidelines: high, intermediate, low, and very low suspicion for malignancy and benign. The reference standard was histopathologic confirmation. Nodules that were smaller at follow-up US were considered benign. The malignancy rate of each category was calculated.
RESULTS: Among a total 191 nodules, 20 (10.5%) were malignant. Solid composition, marked hypoechogenicity, microlobulated or irregular margins, microcalcifications, and taller-than-wide shape were more frequently seen in malignant nodules (all p < 0.001). The malignancy rate of nodules with very low suspicion of malignancy was 0% (0/58); low, 0% (0/45); intermediate, 10.3% (6/58); and high, 46.7% (14/30) (p < 0.001).
CONCLUSION: When US findings of thyroid nodules are assessed according to the 2015 ATA guidelines, nondiagnostic thyroid nodules with very-low- or low-suspicion US patterns can be followed up with US. Nondiagnostic nodules with intermediate or highly suspicious US patterns should be evaluated with repeat US-guided fine-needle aspiration biopsy.

Entities:  

Keywords:  Bethesda system; nondiagnostic; reporting; thyroid gland; thyroid nodule; ultrasound

Mesh:

Year:  2017        PMID: 29091005     DOI: 10.2214/AJR.17.18532

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  IS REPEAT FNAB NECESSARY FOR THYROID NODULES WITH ND / UNS CYTOLOGY?

Authors:  R Uçak; D Türkyilmaz Mut; C Kaya; B Yilmaz Ozguven; F Kabukcuoglu; M Uludağ
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

2.  The combination of ATA classification and FNA results can improve the diagnostic efficiency of malignant thyroid nodules.

Authors:  Zhenzhen Wang; Xiangying Zhu; Xiaohui Yu; Haixia Guan; Lei Zhao; Yixia Zhang; Yuge Li; Liang Sang; Yuchen Han; Yushu Li; Zhongyan Shan; Weiping Teng
Journal:  Endocr Connect       Date:  2020-09       Impact factor: 3.335

3.  Assessment of diagnostic capacity and decision-making based on the 2015 American Thyroid Association ultrasound classification system.

Authors:  Luis-Mauricio Hurtado-Lopez; Alfredo Carrillo-Muñoz; Felipe-Rafael Zaldivar-Ramirez; Erich Otto Paul Basurto-Kuba; Blanca-Estela Monroy-Lozano
Journal:  World J Methodol       Date:  2022-05-20

Review 4.  Contemporary Thyroid Nodule Evaluation and Management.

Authors:  Giorgio Grani; Marialuisa Sponziello; Valeria Pecce; Valeria Ramundo; Cosimo Durante
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.